Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone
- PMID: 17996417
- DOI: 10.1016/j.diagmicrobio.2007.09.017
Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone
Abstract
We report the use of tigecycline, firstly with colistin and finally alone, in a patient with a persistent breakthrough bacteremia due to a Klebsiella pneumoniae isolate harboring a metallo-beta-lactamase (VIM-1) and an extended-spectrum beta-lactamase (SHV-12). Time-kill studies demonstrated that the combination of both compounds was synergistic along the first 12 h, suppressing the regrowth observed after 3 to 6 h when colistin was tested alone.
Comment in
-
Tigecycline for treating bloodstream infections: a critical analysis of the available evidence.Diagn Microbiol Infect Dis. 2008 Jul;61(3):358-9; author reply 360-1. doi: 10.1016/j.diagmicrobio.2008.01.025. Epub 2008 Mar 14. Diagn Microbiol Infect Dis. 2008. PMID: 18342476 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous